Notice type: Advisory
pharmacists, retailers of veterinary medicines, animal owners.
All veterinary medicinal products carry certain risks and it is therefore important that prescribers and users of the medicines are aware of the potential issues that can arise.
The HPRA and the EMA continually monitor the safety and efficacy of veterinary medicinal products on the market. When new information becomes available that affects the benefit risk balance of the medicine, the information can lead to regulatory action to mitigate any adverse or untoward event. Reporting of any cases of suspected adverse events, or lack of expected efficacy, can therefore help to safeguard animal health and welfare, and prevent untoward effects in animals or persons using the products concerned.
Veterinary practitioners and health care professionals
should note the contents of the bulletin.